The board of directors of AbbVie Inc (NYSE:ABBV) declared on Thursday its quarterly dividend of USD0.96 per share of its stock.

This cash dividend will be paid on 15 August 2018 to stockholders of record at the close of business as of 13 July 2018.

Since the company's inception in 2013, the company has raised its dividend by 140%.

According to the research-driven biopharmaceutical company, it is committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. In more than 75 countries, its employees are working every day to advance health solutions for people around the world.